Thanks to advances in molecular biotechnology techniques, we are producing vast quantities of data more quickly than ever before - and that data also drills down to increasingly detailed levels. Naturally, more - and increasingly complex - data brings with it new data analytics challenges. Ensuring ...
No biologist likes a black box. As scientists, we’re skeptical - we want to know why something works, and how something works - not just that it works. And that’s for good reason! Biology, as you know, is very complex, and we’re still only just scraping the surface in terms of understanding how the ...
As we covered in our recent blog series, we expect advances in single cell sequencing to have an important impact on biomedicine. We predict that new technologies and tools like high-throughput single cell sequencing, spatial technologies, and increased public availability of data atlases will ...
Artificial Intelligence (AI) is swiftly becoming a cornerstone technology in the early stages of drug discovery and preclinical development. We're witnessing an increasing number of AI-driven breakthroughs in this field… right? Let’s take a critical look together.
Lausanne (Switzerland) and Ghent (Belgium), 23rd January 2024 - Today we are proud to announce the incorporation of BioLizard SA and the opening of new offices at Biopôle in Lausanne, home to one of the largest biotech hubs in Switzerland. With this new foothold, we continue our international ...
